Detailed Information on Publication Record
2021
Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study
CARDOSO, R., F. GUO, T. HEISSER, M. HACKL, P. IHLE et. al.Basic information
Original name
Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study
Authors
CARDOSO, R., F. GUO, T. HEISSER, M. HACKL, P. IHLE, H. DE SCHUTTER, N. VAN DAMME, Z. VALERIANOVA, T. ATANASOV, Ondřej MÁJEK (203 Czech Republic, belonging to the institution), Jan MUŽÍK (203 Czech Republic, belonging to the institution), M. C. NILBERT, A. J. TYBJERG, K. INNOS, M. MAGI, N. MALILA, A. M. BOUVIER, V. BOUVIER, G. LAUNOY, A. S. WORONOFF, M. CARIOU, M. ROBASZKIEWICZ, P. DELAFOSSE, F. PONCET, A. KATALINIC, P. M. WALSH, C. SENORE, S. ROSSO, I. VINCERZEVSKIENE, V. E. P. P. LEMMENS, M. A. G. ELFERINK, T. B. JOHANNESEN, H. KORNER, F. PFEFFER, M. J. BENTO, J. RODRIGUES, F. A. DA COSTA, A. MIRANDA, V. ZADNIK, T. ZAGAR, A. L. D. MARQUES, R. MARCOS-GRAGERA, M. PUIGDEMONT, J. GALCERAN, M. CARULLA, M. D. CHIRLAQUE, M. BALLESTA, K. SUNDQUIST, J. SUNDQUIST, M. WEBER, A. JORDAN, C. HERRMANN, M. MOUSAVI, A. RYZHOV, M. HOFFMEISTER and H. BRENNER (guarantor)
Edition
Lancet Oncology, New York, Elsevier Science INC, 2021, 1470-2045
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30204 Oncology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 54.433
RIV identification code
RIV/00216224:14110/21:00121970
Organization unit
Faculty of Medicine
UT WoS
000668269600045
Keywords in English
colorectal cancer; incidence; mortality; stage distribution; Europe
Tags
International impact, Reviewed
Změněno: 23/7/2021 13:32, Mgr. Tereza Miškechová
Abstract
V originále
Findings In countries with long-standing programmes of screening colonoscopy and faecal tests (ie, Austria, the Czech Republic, and Germany), colorectal cancer incidence decreased substantially over time, with AAPCs ranging from -2 center dot 5% (95% CI -2 center dot 8 to -2 center dot 2) to -1 center dot 6% (-2 center dot 0 to -1 center dot 2) in men and from -2 center dot 4% (-2 center dot 7 to -2 center dot 1) to -1 center dot 3% (-1 center dot 7 to -0 center dot 9) in women. In countries where screening programmes were implemented during the study period, age-standardised colorectal cancer incidence either remained stable or increased up to the year screening was implemented. AAPCs for these countries ranged from -0 center dot 2% (95% CI -1 center dot 4 to 1 center dot 0) to 1 center dot 5% (1 center dot 1 to 1 center dot 8) in men and from -0 center dot 5% (-1 center dot 7 to 0 center dot 6) to 1 center dot 2% (0 center dot 8 to 1 center dot 5) in women. Where high screening coverage and uptake were rapidly achieved (ie, Denmark, the Netherlands, and Slovenia), age-standardised incidence rates initially increased but then subsequently decreased. Conversely, colorectal cancer incidence increased in most countries where no large-scale screening programmes were available (eg, Bulgaria, Estonia, Norway, and Ukraine), with AAPCs ranging from 0 center dot 3% (95% CI 0 center dot 1 to 0 center dot 5) to 1 center dot 9% (1 center dot 2 to 2 center dot 6) in men and from 0 center dot 6% (0 center dot 4 to 0 center dot 8) to 1 center dot 1% (0 center dot 8 to 1 center dot 4) in women. The largest decreases in colorectal cancer mortality were seen in countries with long-standing screening programmes.